Skyrizi is a medication used to treat moderate to severe plaque psoriasis in adults. It works by blocking a specific protein in the body that causes inflammation, leading to the improvement of psoriasis symptoms. Skyrizi is given as an injection and is typically administered every 12 weeks after the initial doses.
However, obtaining access to Skyrizi enrollment forms can be time consuming and confusing. In this article, we will provide you with access to Skyrizi enrollment forms and introduce you to the Skyrizi Nurse Ambassador™ program, which provides resources to assist your patients in their management of Skyrizi.